clariti® 1 day multifocal with Binocular Progressive System



![]()




Overview
Product name: clariti® 1 day multifocal with Binocular Progressive System
Launch and product ordering availability date: 1st June 2026



Existing Wearers: Switch from clariti® 1 day multifocal 2 Add to NEW clariti® 1 day multifocal with Binocular Progressive System offering upgraded technology at no extra cost
New Wearers: Affordable entry-level lens with good value for money, providing value and quality to the wearer
Pricing
No price change from the current clariti® 1 day multifocal 2 Add lens
Timelines
1st June 2026 clariti® 1 day multifocal with Binocular Progressive System revenue and trial packs available
1st Sept 2026 clariti® 1 day multifocal 2 Add trials discontinued

1st June 2027 clariti® 1 day multifocal 2 Add revenue packs discontinued

Base curve 8.6mm
Diameter 14.1mm
Power Range +8.00D to -10.00D (0.25D) -10.50D to -12.00D (0.50D)
Add Power
Low (+0.75D to +1.25D spectacle Rx add)
Med (+1.50D to +1.75D spectacle Rx add)
High (+2.00D to +2.50D spectacle Rx add)

CooperVision® Binocular Progressive System


The redesigned clariti® 1 day multifocal lens features the CooperVision® Binocular Progressive System , an innovative 3 Add multifocal system first introduced in MyDay® daily disposable multifocal to optimise vision for all levels of presbyopia, even as prescription and vision needs change1 . This means patients can stay in the new redesigned clariti® 1 day multifocal lens as their presbyopia progresses.


Customers will enjoy great comfort and value with the upgraded clariti® 1 day multifocal contact lens
• Great value, entry level lens1
• Optomised Comfort Edge ensures high level of comfort from first fit2


• Wetloc Technology. Naturally wettable for excellent all-day comfort3

• Refit is recommended for existing wearers of clariti® 1 day multifocal 2 add needing to transition to the NEW clariti® 1 day multifocal with Binocular Progressive Technology



• A range of collateral is available to support including a new Fitting Guide; NEW clariti® 1 day multifocal with Binocular Progressive Technology is also included in OptiExpert OptiExpert is an





• Using up-to-date spectacle prescription, determine spherical equivalent distance power (corrected for vertex distance).
• Determine sensory eye dominance with +1.00D blur method; if inconclusive, use +1.50D or more.
• Select distance sphere power for each eye with add powers as indicated in the table to the right.
fitting success rate with two pairs or fewer
This fitting guide is effective in supporting a so you can easily and successfully find the right


• For best results, allow wearer to experience vision outside the testing room for 10-15 minutes.
• Check patient’s vision with both eyes open and room lights on.
• Assess vision at different viewing distances.
For distance vision, assess in surrounding environment under normal lighting conditions.
For near vision, assess using a mobile phone or other reading material.
• If vision acceptable, dispense trial lenses.
• If vision not acceptable, follow the lens optimisation steps described below
Have patient keep both eyes open and optimise using handheld lenses or a flipper; do not use a phoropter.
DO NOT CHANGE ADD POWER.
Follow this fitting guide or use OptiExpert™ for initial lens selection. Download OptiExpert™ from the App Store or Google Play, or access at: www.coopervision.net.au/practitioner/tools-and-calculators www.coopervision.co.nz/practitioner/tools-and-calculators



clariti® 1 day multifocal 3 Add
Base Curve 8.6mm
Diameter 14.1mm

Range +8.00D to -10.00D (0.25 steps) -10.50D to -12.00D (0.50D steps)
Add Power Low (+0.75D to +1.25D spectacle Rx add)
Med (+1.50D to +1.75D spectacle Rx add)
High (+2.00D to +2.50D spectacle Rx add)
Material somofilcon A
Dk/t (at -3.00D) 86
UV Blocking* Class 2
When determining spectacle prescription add, consider patients’ main lifestyle vision needs (mobile phone or other reading material, wdesktop computer, etc.).
Prescribe maximum plus power for binocular distance vision; do not over minus.
Use loose handheld lenses or flipper for over-refractions. Do not use a phoropter.

to -10.00D (0.25 steps)
to -12.00D (0.50D steps)
Add Power Low (+0.75D to +1.25D spectacle Rx add) Med (+1.50D to +1.75D spectacle Rx add) High (+2.00D to +2.50D spectacle Rx add)
Material stenfilcon A
Dk/t (at -3.00D) 100
UV Blocking* Class 2 MyDay® multifocal
*Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed. Please note that clariti® 1 day multifocal with CooperVision® Binocular Progressive System™ is a different multifocal design than the original clariti® 1 day multifocal. Use this fitting guide to select the correct prescription when refitting existing clariti® 1 day multifocal wearers.
• If distance vision needs to be enhanced, offer ±0.25D to the dominant eye. If distance vision improves, check that near vision is maintained. Adjust the lens sphere power as applicable for the dominant eye. DO NOT CHANGE ADD POWER.
• If near vision needs to be enhanced, offer ±0.25D to the non-dominant eye. If near vision improves, check that distance vision is maintained. Adjust the lens sphere power as applicable for the non-dominant eye. DO NOT CHANGE ADD POWER.




Let patients know that some shadowing or blurring may be expected for a few weeks.2
References: 1. CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; n=90 habitual multifocal lens wearers 2. Potter R, Pal S, Stiegemeier MJ. Avoiding the soft multifocal failure. Contact Lens Spectrum. 2016;31:22-25. clariti® and CooperVision® are registered trademarks of the Cooper Companies, Inc. and its subsidiaries. ©2026 CooperVision Australia Pty Ltd, 115 Hayward Avenue, Torrensville, SA 5031. ABN 12 060 200 553. Email: cs@au.coopervision.com OR sales@coopervision.co.nz. Always read the label and follow the directions for use https://coopervision.net.au/patient-instruction or https://coopervision.co.nz/patient-instruction. April 2026. FR11777. SA17861
